These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer. Larchian WA, Horiguchi Y, Nair SK, Fair WR, Heston WD, Gilboa E. Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741 [Abstract] [Full Text] [Related]
14. Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response. Furukawa J, Hara I, Nagai H, Yao A, Oniki S, Fujisawa M. J Urol; 2006 Sep; 176(3):1198-203. PubMed ID: 16890725 [Abstract] [Full Text] [Related]
15. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. Nakano H, Kishida T, Asada H, Shin-Ya M, Shinomiya T, Imanishi J, Shimada T, Nakai S, Takeuchi M, Hisa Y, Mazda O. J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036 [Abstract] [Full Text] [Related]